Molndal, Sweden

Anna Ingrid Kristina Berggren

This inventor holds 5 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Astrazeneca Ab. Active years: 2008-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna Ingrid Kristina Berggren. Retrieved from https://idiyas.com/inventor/anna-ingrid-kristina-berggren

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 80.0

 

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Mölndal, SE (2008 - 2024)
  • Göthenburg, SE (2024)

Company Filing History:


Years Active: 2008-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Anna Ingrid Kristina Berggren: Innovator in Pharmaceutical Chemistry

Introduction

Anna Ingrid Kristina Berggren is a prominent inventor based in Mölndal, Sweden. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target various diseases. With a total of 5 patents to her name, her work has the potential to impact the treatment of respiratory diseases, cancer, and autoimmune disorders.

Latest Patents

Among her latest patents is a groundbreaking application titled "Substituted indazoles as IRAK4 inhibitors." This patent relates to chemical compounds that inhibit IRAK4 and can be utilized in treating respiratory diseases, cancer, inflammatory diseases, and autoimmune conditions. Another notable patent is for "JAK1 selective inhibitors," which discloses compounds that have specific pharmaceutical applications. These innovations highlight her commitment to advancing medical science through her research.

Career Highlights

Throughout her career, Anna has worked with AstraZeneca AB, a leading global biopharmaceutical company. Her role at AstraZeneca has allowed her to contribute to significant advancements in drug development and therapeutic solutions. Her expertise in pharmaceutical chemistry has positioned her as a key player in her field.

Collaborations

Anna has collaborated with notable professionals in her industry, including Karl Magnus Nilsson and Johan R Johansson. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Anna Ingrid Kristina Berggren is a distinguished inventor whose work in pharmaceutical chemistry continues to pave the way for new treatments. Her patents and collaborations reflect her dedication to improving healthcare through innovative solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…